ASTH Historical PE Ratio Notes

— Astrana Health (ticker ASTH) is a healthcare services company that primarily partners with physicians, health plans, and hospitals to deliver value-based care. Its business model revolves around enabling more efficient, coordinated healthcare, driving better patient outcomes while controlling costs—especially within government-sponsored programs like Medicare Advantage and Medicaid. Because Astrana generates revenue via shared savings, care management fees, and capitation agreements, its earnings can fluctuate based on enrollment trends, medical cost control, and success in improving patient metrics. As you review ASTH's historical price, earnings, and PE ratio data, keep in mind that the stock market's valuation of Astrana's earnings often reflects both broader trends in managed care and investor sentiment about the company's ability to sustainably grow profits in a highly regulated, competitive sector. Periods of earnings volatility, expansion into new markets, or changes in risk arrangements may drive changes in the historical PE ratio. A lower PE might coincide with investor concerns about regulatory headwinds or profitability challenges, while a higher PE may reflect optimism about Astrana's growth potential — especially when efficiency improvements and membership gains appear robust.

On this page we presented the ASTH Historical PE Ratio information for Astrana Health' stock. The average ASTH historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 33.3. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ASTH historical PE based on this TTM earnings result method is 53.8. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ASTH historical PE result, against the recent PE: when this page was posted on 3/13/2026, the most recent closing price for ASTH had been 24.26, and the most recent quarterly earnings result, annualized, was 2.16. Meanwhile, the most recent TTM earnings summed to 0.88. From these numbers, we calculate the recent ASTH PE on 3/13/2026 based on annualized quarterly EPS was 11.2. Based on ASTH's history, that recent PE is low relative to the historical average, with the recent PE 66.4% lower than the historical average PE across our data set for Astrana Health. Looking at the recent ASTH PE on 3/13/2026 based on TTM EPS, we calculate the ratio at 27.6. Based on ASTH's history, that recent PE is low relative to the historical average, with the recent PE 48.7% lower than the average PE across our Astrana Health data set with TTM EPS used in the calculation at each period.

Another interesting ASTH historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for ASTH, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for ASTH, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.01, 0.14, 0.19, and 0.54. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.14 and 0.19 — which gives us the median of 0.17. Basically the way to think about this 0.17 number is this: for the trailing four earnings reports, 0.17 marks the "middle ground" number where ASTH has reported a value higher than 0.17 half the time, and has reported a value lower than 0.17 half the time. Annualizing that median value then gets us to 0.68/share, which we use as the denominator in our next PE calculation. With 24.26 as the numerator (as of 3/13/2026), the calculation is then 24.26 / 0.68 = 35.7 as the ASTH PE ratio as of 3/13/2026, based on that annualized median value we calculated.

For self directed investors doing their due diligence on ASTH or any other given stock, valuation analysis for ASTH can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Astrana Health PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ASTH. Thanks for visiting, and the next time you need to research ASTH Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.